DENILEUKIN DIFTITOX | Protein | none | Elongation factor 2 inhibitor | 4 | ['Completed', 'Completed', 'Terminated', 'Completed', 'Recruiting', 'Terminated', 'Completed', 'Terminated', 'Completed', 'Terminated', 'Completed', 'Terminated', 'Withdrawn', 'Unknown status', 'Terminated', 'Completed', 'Completed', 'Terminated', 'Withdrawn', 'Completed', 'Completed', 'Completed', 'Completed', 'Withdrawn', 'Terminated', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Unknown status', '-', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', '-', 'Terminated', 'Terminated', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'DailyMed', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
MOXETUMOMAB PASUDOTOX | Antibody | none | Elongation factor 2 inhibitor | 4 | ['Completed', 'Terminated', 'Completed', 'Unknown status', 'Unknown status', '-', 'Terminated', '-', 'Terminated', 'Completed', 'Terminated', 'Unknown status', 'Terminated', 'Recruiting', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
TAGRAXOFUSP | Protein | none | Elongation factor 2 inhibitor | 4 | ['-', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Terminated', 'Active, not recruiting', '-', 'Recruiting'] | ['ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials'] |
LMB-100 | Unknown | none | Elongation factor 2 disrupting agent | 2 | ['Active, not recruiting', 'Terminated', 'Completed', 'Terminated', 'Completed', 'Terminated', 'Recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
RESIMMUNE | Unknown | none | Elongation factor 2 inhibitor | 2 | ['Completed', 'Completed', 'Unknown status', 'Terminated', 'Completed', 'Unknown status'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |